Created at 12:37 a.m. Sep, 01, 2026
Author: jiffypeople
Related Note: 1462913839886 7
Rationale for change

latest ADA guidelines recommend SGLT2 inhibitors as long as GFR >=20, and there is benefit of slowing progression of DM CKD

image source: https://doi.org/10.2337/dc25-S011
Source: Society Guidelines - https://doi.org/10.2337/dc25-S011

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::#SketchyIM::05_Endocrinology::01_Diabetes_Mellitus::02_Diabetes_Management #AK_Step1_v12::#AMBOSS::mdaVqj #AK_Step1_v12::#UWorld::COMLEX::23717 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#OME::04_Organ_Systems::06_Endocrine::05_Pancreas::03_Diabetes_Pharmacology #PANCE::EOR::IM #AK_Step1_v12::#FirstAid::08_Endocrine::05_Pharm::01_Diabetes_mellitus_therapy::*SGLT2_Inhibitors #AK_Step1_v12::#Textbooks::#Cecil::068_Diabetes_Mellitus_Hypoglycemia #AK_Step1_v12::#Bootcamp::Endocrinology::07_Pancreas::09_Diabetes_Type_2_Management #AK_Step2_v12::#CMS::IM::Form_06 #AK_Step1_v12::#Textbooks::#Golan_Pharmacology::31_Pharmacology_Of_The_Endocrine_Pancreas_and_Glucose_Homeostasis #AK_Step1_v12::#AMBOSS::0WaePj #AK_Other::Only_Step_1 #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::06_Retired_Lessons::03_Metformin,_thiazolidinediones,_pramlintide,_SGLT2_inhibitors_[Retired_Video] #AK_Step1_v12::#OME::PreClinical::04_Organ_Systems::06_Endocrine::05_Pancreas::03_Diabetes_Pharmacology #AK_Step1_v12::#Physeo::09_Pharm::07_Endocrine::07_Sodium-glucose_Cotransporter_2_(SGLT2)_Inhibitors #AK_Step2_v12::#Bootcamp::Medicine::05_Endocrinology::01_Disorders_of_Glucose_Metabolism::05_Diabetes_Pharmacotherapy #AK_Step1_v12::#Pixorize::03_Pharmacology::07_Diabetes_Drugs_(New)::09_SGLT2_Inhibitors #PANCE::ENDO::diabetes #AK_Step1_v12::#UWorld::Step::604 #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::02_Diabetes::02_Metformin,_Thiazolidinediones,_Pramlintide,_SGLT2_Inhibitors #AK_Step1_v12::^Systems::Endocrine::Pharmacology #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology